Daplyza-M Tablets

Daplyza-M – Synergistic Therapy for Type 2 Diabetes

Daplyza-M is a high-performance combination medication that unites Dapagliflozin and Metformin HCl in a single convenient tablet. It is specifically indicated for the treatment of type 2 diabetes mellitus in adults as an adjunct to a healthy diet and regular physical activity. This combination is particularly effective for patients whose blood sugar levels are insufficiently controlled on metformin monotherapy. By bringing two potent agents together, Daplyza-M attacks the root causes of hyperglycemia from two distinct directions.

Metformin works by reducing the liver's production of glucose and improving the way the body handles its natural insulin. Dapagliflozin works by helping the kidneys filter excess sugar out of the blood and releasing it into the urine. Together, they provide comprehensive 24-hour control of glucose levels, helping patients reach and maintain their target HbA1c. Beyond blood sugar management, the combination has been shown to offer significant protection for the heart and kidneys in diabetic individuals. It is typically taken twice daily with meals to ensure maximum efficacy and gastrointestinal tolerance. This medication is a cornerstone in preventing the long-term, debilitating complications of chronic diabetes.

• Indicated for adults with type 2 diabetes needing dual therapy.
• Combines liver-targeting and kidney-targeting glucose control.
• Provides significant cardiovascular and renal protection.
• Available as: Tablets 5mg+850mg and 5mg+1000mg.